Episode notes
Recorded live at Health Supernova 2025, Nick Spiller and Susanna Harris discuss how hospitals are ripe for innovation yet riddled with bureaucratic “antibodies” that reject anything new.
In this episode, Harris shares how deep-tech startups can navigate that resistance: by identifying decision-makers, uncovering the unspoken reasons behind a “no,” and proving not only clinical value but economic impact. She breaks down the difference between a bedside innovation clinicians love and a procurement nightmare administrators block—and explains why your internal champion must speak both languages. The result is a tactical roadmap for bringing breakthrough diagnostics, AI triage tools, and bio-manufacturing platforms from pilot projects to system-wide adoption.
Bringing a medical device to life? DesignPlex Biomedical ...